Pharmacy Podcast Network

Act Early to Lighten the Heavy Burden of T2D | T2D: Don’t Sugar Coat It

What is the burden of the type 2 diabetes (T2D) epidemic? Join experts in T2D: Dr John Anderson (primary care provider), Dr Susan Cornell (clinical pharmacist and certified diabetes care and education specialist) and Dr Doron Schneider (primary care provider) as they discuss the physical, emotional, psychological and economic burden of T2D and its comorbidities on the US healthcare system and on their patients and what they, as clinicians need to do to ease this burden.
John E. Anderson, MD
Susan Cornell, BS, PharmD, CDCES, FAPhA, FADCES
Doron Schneider, MD, MBA, FACP
 
 

Mapping a Successful Herbal Career by Going Deep w/ Sara Chana Silverstein | The Holistic Pharmacy Podcast

Hello dear ones! I am over the moon and beyond grateful to share this next episode with you, where I got to interview one of my herbal teachers. We go deep into clinical pearls from this super-experienced powerhouse of a woman who’d like you to take away the following bottom line: the herbs are here to help heal us, they’re inexpensive, safe and easy to use.Sara-Chana Silverstein is the author of the book MOODTOPIA: Tame your moods, de-stress, and find balance using herbal remedies...which has been #1 on Amazon. Her book got accolades from Mayim Bialik, Deepak Chopra, and Christie Brinkley.She is a Master Herbalist RH (AHG), Classical Homeopath, Board-certified lactation consultant (IBCLC), wife, keynote speaker, and mother of seven children. She is regularly featured on TV news shows across the US discussing how people can safely integrate alternative medicine with conventional medicine. She is a consultant to many pediatricians, midwives, general doctors, and guest lectures to residents at medical schools.After working with over 45,000 clients for the past 28 years she saw that most people needed help with their moodiness and created a program that teaches people how to: “BE IN CONTROL OF YOUR MOODS, SO THEY DON'T CONTROL YOU."Connect with Sara Chana via:Instagram @sarachanas Website moodtopiabook.com Sarachana.com *Enter the raffle for free bottle of herbs by sending your email and phone number tomoodtopiabook@gmail.com

Using Technology to Decrease Barriers to the Clinical Implementation of Pharmacogenomics: LetsGetChecked’s PGx Story | PGx For Pharmacists

On this episode, Dr. Avni Santani, Chief Genomics Officer of Let's Get Checked, Dr. Behnaz Sarrami, and I discuss how Let's Get Checked solves several major barriers that have held pharmacogenomics back from becoming the standard of care in medication therapy management, pharmacists' critical and unique role in PGX at Let's Get Checked, and how nontraditional PGx payers are championing for PGx testing to decrease adverse drug events, increase therapeutic medication outcomes, and improve patient adherence to their medications.  https://www.letsgetchecked.com/mypgx/Becky Winslow, BS, PharmD and Behnaz Sarrami, MS, PharmD (Hosts) Avni A. Santani, PhD, FACMG, Chief Genomics Officer at LetsGetChecked
New boost

5 Things to Know About the Inflation Reduction Act | The PUTTcast

What does the IRA really achieve when it comes to prescription medications? What are its effects on independent pharmacies, the 340B program, or even DIR fees? What parts of the equation are missing, and what inclusions would make the IRA better for everyone?
 
Listen in as PUTTcast hosts Monique Whitney and Lauren Young take a deep dive into the answers to these questions and many more with special guest American Pharmacies General Counsel, Miguel Rodriguez.

Ketamine: Anesthetic and rapid anti-depressant | Neural Pharm Podcast

Ketamine is among the most unique pharmaceutical agents on the market. Join us on an exploration of the research on its neuropharmacology and use for depression, and discussion of risks and benefits.
References:
Article referenced in the beginning:
Martinez-Marmol, et al. Hericerin derivatives activates a pan neurotrophic pathway in central hippocampal neurons converging to ERK1/2 signaling enhancing spacial memory. Journal of Neurochemistry. 2023(165);6: 791-808
 
Ballard E and Zarate C. The role of disassociation in ketamine’s anti-depressant effects. Nature Communications. 2020: 6431
Bobo WV, et al. Ketamine for treatment resistant unipolar and bipolar major depression: Critical review and implications for clinical practice. Depression and Anxiety. 6 April 2016.
Esketamine [package insert]. Janssen Neuroscience. July 2023.
Fava M, et al. Double blind, placebo controlled dose ranging trial of intravenous ketamine as adjunctive therapy in treatment resistant depression (TRD). Molecular Psychiatry. 2020(25): 1592-1603
Gales A, Maxwell S. Ketamine: recent evidence and clinical uses. World Federation of Societies of Anesthesiologists. 12 June 2018.
Johnston JN, et al. Ketamine in neuropsychiatric disorders: an update. Neuropsychopharmacology. 2023
Loo CK, et al. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular, and subcutaneous routes for ketamine in depression. Acta Psychiatria Scandinavica. 30 March 2016.
Mandal S, et al. Efficacy of Ketamine therapy in the treatment of depression. Indian Journal of Psychiatry. 2019 Sept-Oct; 61(5).
VA/DoD Clinical Practice Guideline. (2022). The Management of Major Depressive Disorder. Washington, DC: U.S. Government Printing Office

Tips For When You’re Ready To Sell Your Pharmacy? | Pharmacy Crossroads

When the time comes to ponder selling your pharmacy it might help to know it is complicated.  Understanding valuation, dealing with licenses, leases and finding a buyer are critical success factors. 
The good news is there are people out there that can help you.  Tim Clark and Owen BonDurant are pharmacists, pharmacy owners and ownership transition experts.  They also help people start, operate and sell pharmacies.  In this episode they layout some of the changes that have occurred in the marketplace in the past year or so.  They also describe some new options for finding buyers that many owners may not know about.  You can check out their website at:   www.independentrxconsulting.com 
 

The Future of LTC Pharmacy | Framework Focus

In this episode, host Mark Fulton and guest Patrick Hussey talk about emerging trends in pharmacy and what the future will look like for LTC pharmacy operators. They highlight both new opportunities and challenges from a regulatory, technological and practice evolution perspective.

AI-Powered Pharmacy Care: Revolutionizing Patient Support and Adherence | Digital Therapeutalks

Imagine being able to use A.I. text interaction with a patient who recently began to use a continuous glucose monitoring device and was able to ask questions and recieve contexual human-like responoses which were documented and tied into the medical records for pharmacist and physician reference? Artifical intelligence (AI) is impacting virtual every aspect of society in one form or another, including through the transformation of the health care industry and all of its sectors. Pharmacy practice is no exception. Medication and treatment plan adherence will be impacted and patients will have access to a first level reference guides backed by human follow up from Providers. Pharmesol Inc. delivers an automated and intelligent HIPAA compliant SMS text message assistant to support all conversations with patients.References: 
The Rise of AI in Pharmacy Practice Presents Benefits and Challenges
 https://www.pharmacytimes.com/view/the-rise-of-ai-in-pharmacy-practice-presents-benefits-and-challengesby Ned Milenkovich, PharmD, JDWhat are smart inhalers?https://www.news-medical.net/health/What-are-Smart-Inhalers.aspxBy Dr. Liji Thomas, MDReviewed by Sophia Coveney

Impact of Guided Weight-Based Medication Dosing in Pediatric Patients with Obesity | The Pediatric Pharmacist Review

https://www.japha.org/article/S1544-3191(23)00028-6/fulltext
"Hannah Palsgraf went to pharmacy school at Albany College of Pharmacy in upstate NY. She completed her PGY1 at John R. Oishei Children's Hospital in Buffalo, NY and went on to complete her PGY2 in pediatrics through Philadelphia College of Pharmacy with the practice site at Children's Regional Hospital at Cooper in Camden, NJ. She currently practices as a Neonatal ICU Clinical Pharmacy Specialist at Cohen Children's Medical Center in New Hyde Park, NY on Long Island."

TWIRx | AION Labs

AION Labs CEO - Mati Gil About AION Labs AION Labs is a first-of-its-kind alliance of global pharma and technology leaders and investors that have come together with one clear mission: to create and adopt gateway AI and computational technologies that will transform the process of drug discovery and development for the betterment of human health.
 
We invite brilliant inventors, scientists and technologists to solve the biggest R&D challenges of today’s pharma with the support and guidance of years of accumulated know-how, data, and experience of our partners.
 
Backed by our partners’ wealth of knowledge and fresh multidisciplinary approach, we combine the ingenuity, agility and innovative instinct of Israel’s start-up ecosystem to create and develop strong companies with disruptive technology which will pave the way to the future of pharma.
 
Our unique venture creation process eliminates the gap between technologies and markets with our built in product-market innovation model.